Literature DB >> 4132990

An inhibitor of histamine release from human leukocytes.

M T Kelly, A White.   

Abstract

Lysates of human leukocytes, prepared by ultrasonic disruption, contained heat-labile histamine-releasing factors. An inhibitor of histamine release was generated from such lysates during thermal inactivation of the histamine-releasing activity. Lysates inactivated at 38 degrees C for 60 min produced up to 90% inhibition of histamine release from human leukocytes. Heated lysates produced significant inhibition (P < 0.001) of leukocyte histamine release induced by goat antihuman IgE (51+/-3% inhibition), compound 48/80 (69+/-7% inhibition), and fresh leukocyte lysate (63+/-6% inhibition). Membrane ultrafiltration and gel-filtration chromatography suggested that the inhibitor was of less than 1,000 molecular weight. The partially purified inhibitor, eluted from Sephadex G-15 and lyophilized, contained no detectable protein or carbohydrate but produced 80-90% inhibition of histamine release at a concentration of only 10 ng/ml. The histamine-releasing factors from lysates of purified suspensions of lymphocytes and granulocytes were fractionated on Sephadex G-25. A single peak of histamine-releasing activity with an estimated molecular weight of 5,000 was detected from each cell type. Incubation of the partially purified histamine-releasing factors at 38 degrees C resulted in generation of an inhibitor of histamine release which was nearly identical to the inhibitor from crude lysates. This natural inhibitor of histamine release, derived from human leukocytes, may provide an endogenous mechanism for the control of histamine release in inflammation.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4132990      PMCID: PMC302622          DOI: 10.1172/JCI107682

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Heparin inhibition of histamine release and its relation to calcium.

Authors:  M E Tidball
Journal:  Fed Proc       Date:  1967 Jan-Feb

2.  Dual effect of lanthanum on histamine release from mast cells.

Authors:  J C Foreman; J L Mongar
Journal:  Nat New Biol       Date:  1972-12-20

3.  Inhibition of the anaphylactic mechanism by sympathomimetic amines.

Authors:  E S Assem; H O Schild
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

4.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Mediators of histamine release from human platelets, lymphocytes, and granulocytes.

Authors:  M T Kelly; R R Martin; A White
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

6.  The in vitro release of leukocyte histamine by staphylococcal antigens.

Authors:  R R Martin; A White
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

7.  Immune mechanisms of reversed type reaginic hypersensitivity.

Authors:  K Ishizaka; T Ishizaka
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

8.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

9.  Microheterogeneity of the carbohydrate group of aspergillus oryzae alpha-amylase.

Authors:  J F McKelvy; Y C Lee
Journal:  Arch Biochem Biophys       Date:  1969-06       Impact factor: 4.013

10.  Histamine release in the dog after leukocyte lysate injection.

Authors:  M T Kelly; R E Brashear; R R Martin; A White
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.